Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features
about
Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistenceThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsNeurocognitive effects of HIV, hepatitis C, and substance use historyCrack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection.HIV+ men and women show different performance patterns on procedural learning tasks.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesPlasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.Drugs of Abuse in HIV infection and neurotoxicity.Neurocognitive impact of substance use in HIV infection.HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria.HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol.Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and ageCare of the human immunodeficiency virus-infected menopausal woman.Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adultsOpiate drug use and the pathophysiology of neuroAIDS.Delay discounting is greater among drug users seropositive for hepatitis C but not HIVEffects of HIV and early life stress on amygdala morphometry and neurocognitive function.Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature reviewHIV and recent illicit drug use interact to affect verbal memory in women.Decision making among HIV+ drug using men who have sex with men: a preliminary report from the Chicago Multicenter AIDS Cohort StudySubstance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.An investigation of the effects of antiretroviral central nervous system penetration effectiveness on procedural learning in HIV+ drug usersApplications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.Clinical contributors to cerebral white matter integrity in HIV-infected individualsNeurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signalingProtective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis CReview: The neuropathology of drug abuse.Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis.Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.Metacognition in persons with substance abuse: Findings and implications for occupational therapists.Effects of sex and HIV serostatus on spatial navigational learning and memory among cocaine users.Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV.Changes in cognitive function in women with HIV infection and early life stress.Neurocognitive profiles of marginally housed persons with comorbid substance dependence, viral infection, and psychiatric illness.
P2860
Q26825762-1928DC93-9B8D-4C89-A518-F967C91826EDQ30410418-FDF837D8-BC77-4D83-BA4F-8F58C27DEFC8Q33582740-DD78E939-3E41-4D56-8DFC-11F0F0CF4BB1Q33614467-F6A0393A-7754-4333-B27D-4EA6FB25AA6CQ33652957-867C917F-B19D-4D38-B226-D612F73720DEQ33875530-C686CF67-7A46-46AB-9D2D-49DCEE1E01EEQ34344968-5F62F267-BF12-4521-8D88-CCBEA788208BQ34561257-94ADF0E5-0A1F-4AE0-9CE5-52E4EB353EEEQ35175447-52DDEF3F-2112-4E89-8C07-31F16AB0F717Q35212027-1F95F892-6BF4-4441-8B38-545E157BFB4BQ35245735-C33832AF-B115-4263-8124-68C14CE96B17Q35765064-92F89DAF-EC79-45A0-84E9-E5306616ABF0Q36034222-DD3EDE5B-F54F-4B10-9738-78E8BCF77776Q36060674-13F67B22-ED05-4B5C-A4B0-DC06997FAE90Q36087139-49793948-A8BB-4B55-AD6A-9B9233289BB9Q36128333-046F3EDC-3435-45B7-8256-42A6AA01C79CQ36162221-4A46748D-4460-4878-91F0-85E5D3599088Q36201412-D571A154-CF74-4749-BFC6-28F39D0319E9Q36268936-C57D0BBB-EADB-4875-B06A-998BF2B2616CQ36619628-DAADBEB4-0A45-4DF9-A133-D589FB7DE9A9Q36638638-193E99DC-556C-4B2E-BBDB-4CDA4EE29F3AQ36773214-36816D43-896F-4A08-8196-D179D3DD980DQ36980033-C580B6AB-580D-4C54-A317-CD845773D7E8Q37149288-4C625EE3-0143-4935-A29B-6A1EB694DEAEQ37273970-7C40D6D8-8438-4307-BABC-B5788DEA840EQ37375961-6A74ED56-D10B-449B-99EC-5A9B4A07046AQ37467991-221D365B-CA55-4738-B9CB-7FBD05E43CC1Q37520967-3873DC85-7BCE-48AF-8EFD-0B7D23905DE0Q37561725-28EAD4A4-EB1B-4B03-BBC3-B269D4580EAAQ37574403-B949807F-D6AB-4CAA-AF97-023EAF60A0E5Q37577536-D5B33FE7-DB63-4232-907A-650601BDC8B3Q37800120-46FA9270-CD26-460F-B7EF-4F8C3AA17359Q38626559-939D6F4E-B923-485A-90EB-703109641523Q38679995-41FC6E5E-D186-4996-9DBE-5DFD7B929426Q38916260-73D17243-6D4F-4019-8C63-BD7CB5873267Q38992434-E5C30AE1-7D54-4887-A867-1F4D193B0D87Q40076396-296AA84D-6E6B-45FC-8DEA-04BAE380C8BFQ40241936-29A74E07-4781-4FDA-9EFC-826E2DB4141FQ40619327-2F2AA63D-C65F-4CA9-BA20-0C88F8FC81CFQ41671596-C42C31AE-7D2F-44A5-8773-D3C58559846B
P2860
Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@ast
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@en
type
label
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@ast
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@en
prefLabel
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@ast
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@en
P2860
P1476
Drug abuse and hepatitis C inf ...... tive and neuroimaging features
@en
P2093
Eileen M Martin-Thormeyer
Robert H Paul
P2860
P2888
P304
P356
10.1007/S11065-009-9101-6
P577
2009-05-27T00:00:00Z